Silvia Rollefstad

TL;DR: The present update extends on the evidence that CVD risk in the whole spectrum of IJD is increased, which underscores the need for CVDrisk management in these patients.

TL;DR: In a large, international cohort of patients with RA, 30% of CVD events were attributable to RA characteristics, indicating that RA characteristics play an important role in efforts to reduce CVD risk among patients withRA.

TL;DR: This study demonstrates for the first time that adaptations of the SCORE algorithm do not provide sufficient improvement in risk prediction of future CVD in RA to serve as an appropriate alternative to the original SCORE.

TL;DR: Patients with RA had more CP compared with controls and patients in CDAI remission, and controls had more stable CP than patients with active disease; these findings point to the importance of achieving remission in RA.

TL;DR: A atherosclerotic CVD risk management and prevention for patients with rheumatoid arthritis closely follows the recommendations for the general population; however, clinicians should be aware of some specific drug–drug interactions in this patient population.